North America Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Country

Publication Month: Jan 2021 | Report Code: TIPRE00018222 | No. of Pages: 102 | Category: Medical Device | Status: Published
Covid

The North America percutaneous mechanical circulatory support devices market is expected to reach US$ 1,749.25 million by 2027 from US$ 645.23 million in 2019; it is estimated to grow at a CAGR of 13.6% from 2020 to 2027.

The increasing geriatric population, increasing prevalence of cardiovascular diseases and shortage of heart donors are the key factors driving the growth of percutaneous mechanical circulatory support devices. However, high costs of these devices and procedures associated with them as well as product recalls, and impact of COVID-19 pandemic on medical device industry is the major factor hindering the Percutaneous Mechanical Circulatory Support Devices market growth in North America.

    

Percutaneous mechanical circulatory support devices offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.

 

Heart transplantation has been accepted as the best treatment for patients with medically refractory end-stage heart failure. A central fact about organ transplantation, and heart transplantation, in particular, is the scarcity of organs for transplant. Annual figures published by NHS Blood and Transplant in 2015, showed that there is still a vast shortage of organ donors. There are currently 286 patients on the waiting list for a heart transplant, compared with 126 in 2010. The number of people desperately waiting for a heart transplant has more than doubled in just five years, according to the latest statistics. According to a report published by Ottawa Heart Institute in April 2018, more than 5,000 Canadians could benefit from a heart transplant. However, only 170 transplants were performed annually in Canada due to chronic heart donor shortage.

Patients with advanced heart failure have a poor prognosis, and a heart transplant is still the best treatment option. However, the scarcity of donors, long waiting times, and an increasing number of unstable patients have favored the development of mechanical circulatory support.

Moreover, according to the Heart Failure Society of America, nearly 5.7 million Americans are suffering from heart failure. The data also suggests that almost 1.4 million persons with CHF are under 60 years of age. The Centers for Disease Control and Prevention (CDC) reports that about half of people who develop heart failure die within five years of diagnosis. The cost of heart failure in the US is estimated to be US$ 30.7 billion each year. According to the Mount Sinai Heart Center, every day in America, 33 people die in need of new organs, and about 115,000 people are languishing on waiting lists.

 

The chronic shortage of heart donors has also led to extend the age limits of donors in certain areas. Thus, the solution to this shortage of heart donors served by the temporarily used percutaneous mechanical circulatory support devices that are also helpful in long-term support for patients suffering from heart failures is likely to be adopted at higher rates in the coming years.

 

North America is witnessing the growing number of COVID-19 cases. Due to coronavirus spreading, many cities are shutting down, causing treatments and doctors/cardiologists appointment cancellation. Companies operating in the percutaneous mechanical circulatory support devices have limited their production of percutaneous mechanical circulatory support devices. As the treatment procedures are directly contacted with patients’ oral fluid that has a possible risk of infections, for the preventing the spread of COVID-19 it is requested to maintain social distancing as there is a greater risk of getting infected with coronavirus due to direct exposure to oral fluids of the patients. Thus, owing to these factors, the increased production for diagnostics test kits and ventilators are likely to hinder the growth of the percutaneous mechanical circulatory support devices market.

 

Mexico Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

Mexico Percutaneous Mechanical Circulatory Support Devices Market, Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :

 

NORTH AMERICA PERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION

 

By Product

  • Intra-Aortic Balloon Pumps
  • VA-Extracorporeal Membrane Oxygenation (ECMO)
  • Short-Term Ventricular Assist Devices (VADs)
    • Impella
    • Tandem Heart

 

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

 

By Country

  • US
  • Canada
  • Mexico

 

Company Profiles

  • Abbott
  • Teleflex Incorporated
  • Abiomed
  • Jarvik Heart, Inc
  • Medtronic

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        North America Percutaneous mechanical circulatory support devices Market – By Product

1.3.2        North America Percutaneous mechanical circulatory support devices Market– By End User

1.3.3        North America Percutaneous mechanical circulatory support devices Market – By Country

2.          North America Percutaneous mechanical circulatory support devices Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          North America Percutaneous Mechanical Circulatory Support Devices Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.2.1        North America – PEST Analysis

4.3        Expert Opinion

5.          North America Percutaneous Mechanical Circulatory Support Devices Market - Key Market Dynamics

5.1        Key Market Drivers

5.1.1        Rising Geriatric Population

5.1.2        Increasing Prevalence of Cardiovascular Diseases & Heart Failures

5.1.3        Shortage of Heart Donors

5.2        Key Market Restraints

5.2.1        Product Recalls

5.2.2        High Cost of Products and Procedures

5.2.3        Impact of COVID-19 Pandemic on Medical Device Industry

5.3        Key Market Opportunity

5.3.1        Growing Healthcare Market

5.4        Market Trend

5.4.1        Consolidation in the Market

5.5        Impact Analysis

6.          Percutaneous Mechanical Circulatory Support Devices Market – North America Analysis

6.1        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue Forecasts and Analysis

7.          North America Percutaneous Mechanical Circulatory Support Devices Market Analysis and Forecasts To 2027 – By Type

7.1        Overview

7.2        North America Percutaneous Mechanical Circulatory Support Devices Market, By Type 2019 & 2027 (%)

7.2.1        North America Percutaneous mechanical circulatory support devices Market Revenue and Forecasts to 2027, By Type (US$ Mn)

7.3        Intra-Aortic Balloon Pumps Market

7.3.1        Overview

7.3.2        North America Intra-Aortic Balloon Pumps Market Revenue and Forecast to 2027 (US$ Mn)

7.4        VA-Extracorporeal Membrane Oxygenation (ECMO) Market

7.4.1        Overview

7.4.1.1         North America VA-Extracorporeal Membrane Oxygenation (ECMO) Market Revenue and Forecasts to 2027 (US$ Mn)

7.5        Short Term Ventricular Assist Devices Market

7.5.1        Overview

7.5.2        North America Short Term Ventricular Assist Devices Market Revenue and Forecast to 2027 (US$ Mn)

7.5.3        Impella Market

7.5.3.1         Overview

7.5.3.2         North America Impella Market Revenue and Forecast to 2027 (US$ Mn)

7.5.4        Tandem Heart Market

7.5.4.1         Overview

7.5.4.2         North America Tandem Heart Market Revenue and Forecasts to 2027 (US$ Mn)

8.          North America Percutaneous Mechanical Circulatory Support Devices Market Analysis – By End-User

8.1        Overview

8.2        North America Percutaneous Mechanical Circulatory Support Devices Market, By End-User 2019-2027 (%)

8.2.1        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecasts to 2027, By End-User (US$ Mn)

8.3        Hospitals Market

8.3.1        Overview

8.3.2        North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

8.4        Ambulatory Surgical Centers Market

8.4.1        Overview

8.4.2        North America Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)

8.5        Others Market

8.5.1        Overview

8.5.2        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.          Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1        Overview

9.2        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

9.3        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Product (US$ Mn)

9.3.1        North America Short Term Ventricular Assist Devices Market Revenue And Forecast to 2027, By Type  (US$ Mn)

9.4        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By End User (US$ Mn)

9.5        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Country (%)

9.6        US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027  (US$ Mn)

9.6.1        US Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecast to 2027  (US$ Mn)

9.6.2        US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027,  By Product (US$ Mn)

9.6.2.1         US Short Term Ventricular Assist Devices Market Revenue And Forecast to 2027, By Type (US$ Mn)

9.6.3        US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027,  By End user (US$ Mn)

9.7        Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

9.7.1        Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecast to 2027 (US$ Mn)

9.7.2        Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027, By Product (US$ Mn)

9.7.2.1         Canada Short Term Ventricular Assist Devices Market Revenue And Forecast to 2027, By Type (US$ Mn)

9.7.3        Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027, By End user (US$ Mn)

9.8        Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

9.8.1        Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecast to 2027 (US$ Mn)

9.8.2        Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027, By Product (US$ Mn)

9.8.2.1         Mexico Short Term Ventricular Assist Devices Market Revenue And Forecast to 2027, By Type (US$ Mn)

9.8.3        Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast to 2027, By End user (US$ Mn)

10.       Impact of COVID-19 Pandemic on North America Percutaneous Mechanical Circulatory Support Devices Market

10.1     North America: Impact Assessment of COVID-19 Pandemic

11.       Company Profiles

11.1     Abbott

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Information

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2     Teleflex Incorporated

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3     Abiomed

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     Swot Analysis

11.3.6     Key Developments

11.4     Jarvik Heart, Inc.

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Overview

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5     Medtronic

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.       Appendix

12.1     About The Insight Partners

12.2     Glossary of Terms

 


LIST OF TABLES

Table 1.            Total Number Of Persons Aged 60 Years Or Above By Region, 2017 & 2050

Table 2.            North America Percutaneous mechanical circulatory support devices Market Revenue and Forecasts To 2027, By Type (US$ Mn)

Table 3.            North America Percutaneous Mechanical Circulatory Support Devices Market Revenue and Forecasts To 2027, By End-User (US$ Mn)

Table 4.            North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Product (US$ Mn)

Table 5.            North America Short Term Ventricular Assist Devices Market Revenue And Forecast To 2027, By Type (US$ Mn)

Table 6.            North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027,  By End User (US$ Mn)

Table 7.            US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Product (US$ Mn)

Table 8.            US Short Term Ventricular Assist Devices Market Revenue And Forecast To 2027, By Type (US$ Mn)

Table 9.            US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 10.         Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027,  By Product (US$ Mn)

Table 11.         Canada Short Term Ventricular Assist Devices Market Revenue And Forecast To 2027, By Type (US$ Mn)

Table 12.         Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 13.         Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Product (US$ Mn)

Table 14.         Mexico Short Term Ventricular Assist Devices Market Revenue And Forecast To 2027, By Type (US$ Mn)

Table 15.         Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By End User (US$ Mn)

Table 16.         Glossary of Terms, Percutaneous Mechanical Circulatory Support Devices Market

 


LIST OF FIGURES

Figure 1.          Percutaneous Mechanical Circulatory Support Devices Market Segmentation

Figure 2.          North America Percutaneous Mechanical Circulatory Support Devices Market Overview

Figure 3.          Intra-Aortic Balloon Pumps Segment Held Largest Share Of Test Type Segment In Percutaneous Mechanical Circulatory Support Devices Market

Figure 4.          US is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.          North America Percutaneous Mechanical Circulatory Support Devices Market - Leading Country Markets (US$ Mn)

Figure 6.          North America PEST Analysis

Figure 7.          Percutaneous Mechanical Circulatory Support Devices Market Impact Analysis Of Driver And Restraints

Figure 8.          North America Percutaneous Mechanical Circulatory Support Devices Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.          North America Percutaneous Mechanical Circulatory Support Devices Market, By Type 2019 & 2027 (%)

Figure 10.        North America Intra-Aortic Balloon Pumps Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        North America VA-Extracorporeal Membrane Oxygenation (ECMO) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        North America Short Term Ventricular Assist Devices Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        North America Impella Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 14.        North America Tandem Heart Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        North America Percutaneous Mechanical Circulatory Support Devices Market, by End-User 2019 & 2027 (%)

Figure 16.        North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        North America Ambulatory Surgical Centers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        North America Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        North America Percutaneous Mechanical Circulatory Support Devices Market Overview, By Country (2019)

Figure 20.        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

Figure 21.        North America Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027, By Country (%)

Figure 22.        US Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

Figure 23.        Canada Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027  (US$ Mn)

Figure 24.        Mexico Percutaneous Mechanical Circulatory Support Devices Market Revenue And Forecast To 2027 (US$ Mn)

Figure 25.        Impact of COVID-19 Pandemic in North American Country Markets

  1. Abbott
  2. Teleflex Incorporated
  3. Abiomed
  4. Jarvik Heart, Inc
  5. Medtronic
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America percutaneous mechanical circulatory support devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the North America percutaneous mechanical circulatory support devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth regional market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00018222
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing